This readme.md is based upon the HX711 readme.md, so it may contain some sections that are not updated yet. This HX712 library has a public interface (API) which is based upon my HX711 library which ...
A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells that dramatically prolongs their effectiveness after being infused into ...
LONDON, Feb 25 (Reuters) - Big Tech’s race to dominate artificial intelligence may soon hit a nasty road bump as U.S. electricity grids struggle to keep pace with the big-spending hyperscalers. Sign ...
Gilead Sciences is expanding its cell therapy pipeline and technological capabilities through the $7.8 billion acquisition of Arcellx, its partner in the development of a multiple myeloma treatment ...
Scientists at Cedars-Sinai have uncovered a surprising repair system in the spinal cord that could open new doors for treating paralysis, stroke, and diseases like multiple sclerosis. They found that ...
Phyx, a universal platform for selective sample enrichment, named finalist for the SLAS2026 New Product Award Atrandi Biosciences, a life sciences tools company advancing single-cell analysis, today ...
Telehealth company Hims & Hers has added Grail’s blood cancer test Galleri to its offerings as the medtech has now sent off data for a potential FDA approval. Galleri works as a simple blood test that ...
Abstract: Load balancing during resource allocation (RA) in multicell multi-input multi-output non-orthogonal multiple access (MC-MIMO-NOMA) poses significant challenges for the deployment of massive ...
Martin F. Dietrich, MD, PhD, discusses the use of the CDK4/6 inhibitor trilaciclib to address myelosuppression associated with chemotherapy in small cell lung cancer. Martin F. Dietrich, MD, PhD, ...
Professor Yongzhe Wun's team at East China University of Science and Technology significantly improved the interfacial contact and mechanical stability of inverted perovskite solar cells by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results